Doximity (DOCS)
(Delayed Data from NYSE)
$29.86 USD
+0.26 (0.88%)
Updated Jun 14, 2024 04:00 PM ET
After-Market: $29.86 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth D Momentum D VGM
Price, Consensus and EPS Surprise
DOCS 29.86 +0.26(0.88%)
Will DOCS be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for DOCS based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for DOCS
Doximity (DOCS) Upgraded to Buy: Here's What You Should Know
Company News for May 20, 2024
DOCS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Doximity (DOCS) Q4 Earnings and Revenues Surpass Estimates
Ahead of Doximity (DOCS) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Organon (OGN) Tops Q1 Earnings and Revenue Estimates
Other News for DOCS
Dr. Martens Executives Granted Performance Shares
Dr. Martens Rewards CFO with Share Award
IN BRIEF: Dr Martens says Permira alters shareholding structure
Dr. Martens Announces Major Shareholder Shift
Dr. Martens PLC Announces Major Shareholding Shift